MDT•prnewswire•
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
Summary
GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S....
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 19, 2025 by prnewswire